Showing results (31-40 of 367) with videos related to
Sort By:
Pageof 37
Medizinische Klinik (Munich, Germany : 1983)|April 12, 1996
[Interleukin 2 based ambulatory therapy of metastatic renal cell carcinoma]J Atzpodien, H Kirchner, H PoliwodaJournal of Cancer Research and Clinical Oncology|January 1, 1993
Renal, metabolic, and hemodynamic side-effects of interleukin-2 and/or interferon alpha: evidence of a risk/benefit advantage of subcutaneous therapyA Schomburg, H Kirchner, J AtzpodienAnti-Cancer Drugs|October 1, 1993
Low dose megestrol acetate can abrogate cachexia in advanced tumor patients receiving systemic interferon-alpha and/or interleukin-2 based antineoplastic therapyM Ackermann, H Kirchner, J AtzpodienActa Haematologica|January 1, 1993
Hematotoxicity of interleukin-2 in man: clinical effects and comparison of various treatment regimensA Schomburg, H Kirchner, J AtzpodienSeminars in Oncology|October 1, 1991
alpha-Interferon and interleukin-2 in renal cell carcinoma: studies in nonhospitalized patientsJ Atzpodien, H Poliwoda, H KirchnerDer Urologe. Ausg. A|November 13, 2002
[Molecular genetic changes in renal cell carcinomas]N Buentig, S Störkel, J AtzpodienCancer Biotherapy & Radiopharmaceuticals|October 18, 2001
13cis- and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatment in vitroM Benthin, I Dallmann, J AtzpodienBiometrics|April 21, 2001
A new approach to modeling daily probabilities of conceptionP Royston, A FerreiraStatistics in Medicine|February 19, 2003
Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigationP Royston, W SauerbreiAnticancer Research|September 1, 1995
Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patientsS Duensing, J Grosse, J AtzpodienPageof 37